Improving Care

Reducing morbidity and mortality and enhancing quality of life

Informing Policy

Transforming health care at the local, national and international levels

Featured Projects

With more than 80 scientists, research at Advancing Health encompasses a wide breadth of areas

COVID-19

The Evidence Speaks

A recurring feature highlighting the latest in Advancing Health research

Our People

In the News

Research Resources

From design to execution, Advancing Health provides a broad range of support services

Work in Progress Seminar Series

Publications

The work of our scientists, research associates, and staff are often found in the pages of top journals. Each year, our researchers publish over 400 peer-reviewed papers.


  • Wong H, Singer J. The relationship between subchondral sclerosis detected with MRI and cartilage loss in a cohort of subjects with knee pain: The Knee Osteoarthritis Progression (KOAP) study.

    February 25, 2015

    Crema MD, Cibere J, Sayre EC, Roemer FW, Wong H, Thorne A, Singer J, Esdaile JM, Marra MD, Kopec JA, Nicolaou S, Guermazi A. The relationship between subchondral sclerosis detected with MRI and cartilage loss in a cohort of subjects with knee pain: The Knee Osteoarthritis Progression (KOAP) study. Osteoarthritis Cartilage. 2014 Apr;22(4):540-6. doi: 10.1016/j.joca.2014.01.006. Epub 2014 Feb 6.  PMID: 24508776.

    Read More

  • Dodek P. Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey.

    February 25, 2015

    Cook D, Duffett M, Lauzier F, Ye C, Dodek P, Paunovic B, Fowler R, Kho ME, Foster D, Stelfox T, Sinuff T, Zytaruk N, Clarke F, Wood G, Cox M, Kutsiogiannis J, Jacka M, Roussos M, Kumar H, Guyatt G; for the CONECCKT-T (Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis) Investigators and the Canadian Critical Care Trials Group. Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: A multicenter survey. J Crit Care. 2014 Jun;29(3):471.e1-9. doi: 10.1016/j.jcrc.2014.01.017. Epub 2014 Feb 5. PMID: 24629574.

    Read More

  • Humphries KH. Prevalence and control of high blood pressure in primary care—results from the German metabolic and cardiovascular risk study (GEMCAS).

    February 25, 2015

    Balijepalli C, Bramlage P, Losch C, Zemmrich C, Humphries KH, Moebus S. Prevalence and control of high blood pressure in primary care—results from the German metabolic and cardiovascular risk study (GEMCAS). Hypertens Res. 2014 Jun;37(6):580-4. doi: 10.1038/hr.2014.40. Epub 2014 Mar 13. PMID: 24621471.

    Read More

  • Cundiff G. A biomechanics model to assess the contribution of pelvic musculature weakness to the development of stress urinary incontinence.

    February 26, 2015

    Yip C, Kwok E, Sassani F, Jackson R, Cundiff G. A biomechanics model to assess the contribution of pelvic musculature weakness to the development of stress urinary incontinence. Comput Methods Biomech Biomed Engin. 2014 Feb; 17(2):163–76. Epub 2012 Apr 11. PMID: 22494663.

    Read More

  • Werker GR, Bansback N, Anis AH. Optimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers.

    February 26, 2015

    Werker GR, Sharif B, Sun H, Cooper C, Bansback N, Anis AH. Optimal timing of influenza vaccination in patients with human immunodeficiency virus: A Markov cohort model based on serial study participant hemoagglutination inhibition titers. Vaccine. 2014 Feb 3;32(6):677-84. doi: 10.1016/j.vaccine.2013.11.103. Epub 2013 Dec 16. PMID 24355089.

    Read More

  • Shojania K. Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis.

    February 26, 2015

    Tsao NW, Shojania K, Marra CA. Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis. Expert Rev Pharmacoecon Outcomes Res. 2014 Feb; 14(1):9–18. Epub 2013 Dec 10. PMID: 24325566.

    Read More

  • Sawatzky R. Particularizing the general: Sustaining theoretical integrity in the context of an evidence-based practice agenda.

    February 26, 2015

    Thorne S, Sawatzky R. Particularizing the general: Sustaining theoretical integrity in the context of an evidence-based practice agenda. ANS Adv Nurs Sci. 2014 Jan-Mar;37(1):5-18. doi: 10.1097/ANS.0000000000000011. Epub Dec 5. PMID: 24317007.

    Read More

  • Sawatzky R. Guidelines for secondary analysis in search of response shift.

    February 26, 2015

    Schwartz CE, Ahmed S, Sawatzky R, Sajobi T, Mayo N, Finkelstein J, Lix L, Verdam MG, Oort FJ, Sprangers MA. Guidelines for secondary analysis in search of response shift. Qual Life Res. 2013 Dec;22(10):2663-73. doi: 10.1007/s11136-013-0402-0. Epub 2013 Apr 10. PMID: 23572398.

    Read More

  • Lynd LD. The preventable burden of productivity loss due to suboptimal asthma control: A population-based study.

    February 26, 2015

    Sadatsafavi M, Rousseau R, Chen W, Zhang W, Lynd LD, Fitzgerald JM; the Economic Burden of Asthma (EBA) study team. The preventable burden of productivity loss due to suboptimal asthma control: A population-based study. Chest. 2014 Apr;145(4):787-93 Epub 2013 Dec 12. PMID: 24337140.

    Read More

  • Lynd LD. Post-hospital syndrome in adults with asthma: A case-crossover study.

    February 26, 2015

    Sadatsafavi M, Lynd LD, Fitzgerald JM. Post-hospital syndrome in adults with asthma: A case-crossover study. Allergy Asthma Clin Immunol. 2013 Dec 23;9(1):49. doi: 10.1186/1710-1492-9-49. PMID: 24364886.

    Read More

  • Richardson CG. Initial impact of tailored web-based messages about cigarette smoke and breast cancer risk on boys’ and girls’ risk perceptions and information seeking: Randomized Controlled Trial.

    February 26, 2015

    Richardson CG, Struik LL, Johnson KC, Ratner PA, Gotay C, Memetovic J, Okoli CT, Bottorff JL. Initial impact of tailored web-based messages about cigarette smoke and breast cancer risk on boys’ and girls’ risk perceptions and information seeking: Randomized Controlled Trial. JMIR Res Protoc. 2013 Dec 10;2(2):e53. doi: 10.2196/resprot.2858.  PMID: 24326101.

    Read More

  • Phang PT. Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer.

    February 26, 2015

    Renouf DJ, Woods R, Speers C, Hay J, Phang PT, Fitzgerald C, Kennecke H. Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer. Am J Clin Oncol. 2013 Dec;36(6):558-64. doi: 10.1097/COC.0b013e318256f5dc. PMID: 22868238.

    Read More